Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 GBX | 0.00% | 0.00% | -16.67% |
04-18 | Stocks recover some of recent Fed talk losses | AN |
04-18 | Surgical Innovations Group Bags UK Distribution Contracts | MT |
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2023 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.67% | 5.84M | - | ||
-4.88% | 182B | C+ | ||
+1.44% | 110B | C | ||
-2.93% | 68.11B | A | ||
+0.71% | 50.53B | B- | ||
+8.42% | 44.8B | B- | ||
+2.84% | 40.7B | B+ | ||
+20.35% | 32.25B | B | ||
+1.71% | 26.53B | A- | ||
+15.25% | 25.02B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SUN Stock
- Ratings Surgical Innovations Group plc